Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.
复制标题
DOI:
10.2105/ajph.2009.188664
复制
发表时间:
2010-10
影响因子:
12.7
通讯作者:
INSIGHT SMART Study Group
中科院分区:
文献类型:
--
作者:
Lifson AR;Neuhaus J;Arribas JR;van den Berg-Wolf M;Labriola AM;Read TR;INSIGHT SMART Study Group
We sought to determine smoking-related hazard ratios (HRs) and population-attributable risk percentage (PAR%) for serious clinical events and death among HIV-positive persons, whose smoking prevalence is higher than in the general population. For 5472 HIV-infected persons enrolled from 33 countries in the Strategies for Management of Antiretroviral Therapy clinical trial, we evaluated the relationship between baseline smoking status and development of AIDS-related or serious non-AIDS events and overall mortality. Among all participants, 40.5% were current smokers and 24.8% were former smokers. Adjusted HRs were higher for current than for never smokers for overall mortality (2.4; P<.001), major cardiovascular disease (2.0; P=.002), non-AIDS cancer (1.8; P=.008), and bacterial pneumonia (2.3; P<.001). Adjusted HRs also were significantly higher for these outcomes among current than among former smokers. The PAR% for current versus former and never smokers combined was 24.3% for overall mortality, 25.3% for major cardiovascular disease, 30.6% for non-AIDS cancer, and 25.4% for bacterial pneumonia. Smoking contributes to substantial morbidity and mortality in this HIV-infected population. Providers should routinely integrate smoking cessation programs into HIV health care.